MS unit7(1) Comprehensive Study Guide on Fluid, Electrolyte, and Acid-Base Imbalances

Body Fluid Compartments and Fluid Distribution

• Fluid Compartment Overview:
  • Total body water is distributed across two primary compartments: intracellular fluid (ICF) and extracellular fluid (ECF).
  • Intracellular Fluid (ICF): Fluid residing inside the cells; represents the most abundant fluid compartment in the human body.
  • Extracellular Fluid (ECF): Fluid residing outside the cells; divided into three sub-compartments:
  • Interstitial Fluid: Fluid located in the spaces between cells, including lymph fluid.
  • Intravascular Fluid: Fluid contained within the vascular system (arteries, veins, and capillaries); composed primarily of blood and blood products.
  • Transcellular Fluid: The smallest sub-compartment, consisting of fluids contained within specific epithelial-lined spaces (e.g., gastric acid, digestive secretions, synovial/joint fluid, and cerebrospinal fluid [CSF]).

Mechanisms of Fluid Movement and Regulation

• Hormonal Regulation via Antidiuretic Hormone (ADH):
  • Secreted by the posterior pituitary gland.
  • Regulates fluid retention by signaling the kidneys to conserve water (anti-diuresis).
  • Contrast with diuretic medications (e.g., furosemide [Lasix]), which induce urinary excretion; ADH causes the renal system to retain water.
• Cellular Transport Mechanisms:
  • Active Transport: Movement of ions or molecules across cell membranes against a concentration gradient, requiring metabolic energy ($\text{ATP}$). An example is the sodium-potassium ion pump ($\text{Na}^+/\text{K}^+\text{-ATPase}$).
  • Passive Transport: Movement requiring no cellular energy expenditure.
  • Diffusion: Passive movement of solutes from an area of higher concentration to lower concentration.
  • Filtration: Movement of water and solutes across a membrane driven by hydrostatic pressure.
  • Osmosis: Movement of water across a semipermeable membrane from an area of low solute concentration to an area of high solute concentration (acting as a diluting mechanism).
• Hemodynamic Pressures:
  • Osmotic Pressure: The hydrostatic/pulling force generated by solute concentration within blood vessels (arteries and veins) that regulates water movement across vascular membranes and helps maintain systemic blood pressure.
  • Osmolarity: The concentration of solutes per volume of solution.

Intravenous Solution Classifications

• Isotonic Solutions:
  • Possess an osmolarity equal to that of human serum; cause no net fluid shifts across cell membranes.
  • Serve as first-line fluid resuscitation in clinical emergencies.
  • Standard formulation: $0.9\%$ sodium chloride ($\text{Normal Saline}$, or $\text{NS}$).
  • Any variation in sodium chloride percentage alters the tonicity to either hypotonic or hypertonic.
• Hypotonic Solutions:
  • Possess an osmolarity lower than that of human serum.
  • Lower solute concentration in the extracellular space drives water into cells, hydrating them.
  • Mnemonic and physiological rule: "Hypo cells swell" (analogized to a swelling hippo).
• Hypertonic Solutions:
  • Possess an osmolarity higher than that of human serum.
  • Higher extracellular solute concentration pulls water out of intracellular spaces into the intravascular space, dehydrating the cells.

Fluid Gains, Losses, and Fluid Balance

• Fluid Intake (Gains):
  • Oral fluid intake, intravenous fluid administration, and enteral feeding tubes (e.g., percutaneous endoscopic gastrostomy [PEG] tube).
• Fluid Excretion (Losses):
  • General outputs include urine, emesis, blood loss, surgical wound drainage, and diarrhea.
  • Sensible Losses: Measurable fluid losses of which an individual is typically conscious (e.g., urinary output).
  • Insensible Losses: Unmeasurable, unnoticed fluid losses (e.g., diaphoresis/sweating, respiratory vapor exhalation, stool moisture).

Fluid Volume Deficit (Dehydration and Hypovolemia)

• Pathophysiology and Etiology:
  • Fluid Volume Deficit / Dehydration: Inadequate total body fluid.
  • Hypovolemia: Deficient fluid volume specifically within the intravascular compartment.
  • Causes include excessive losses (hemorrhage, severe diaphoresis, vomiting, diarrhea, draining wounds), prolonged NPO (nil per os) status, endocrine disorders, and medication-induced loss (diuretic therapy).
• Third Spacing:
  • Pathological shift of extracellular fluid out of the intravascular space into interstitial or transcellular compartments, rendering it biologically unavailable for circulatory perfusion and risking hypovolemic shock.
  • Edema: Fluid shift into interstitial tissues, commonly triggered by trauma or severe burns (body diverts intravascular fluid to injured sites to reduce heat).
  • Ascites: Accumulation of fluid within the peritoneal cavity; typically secondary to hepatic dysfunction, liver failure, or cirrhosis (frequently associated with chronic alcohol abuse).
  • Clinical caveat: Patients can simultaneously present with severe interstitial edema and profound intravascular hypovolemia.
• Clinical Manifestations:
  • Cardiovascular: Compensatory tachycardia with a weak, thready pulse; arterial hypotension due to low circulating blood volume.
  • Respiratory: Compensatory tachypnea to maximize oxygen distribution despite reduced circulating fluid volume.
  • Integumentary and Mucosal: Thirst (initial manifestation), dry oral mucosa, sticky mucous membranes, "furrows of the tongue" (cracked, parched tongue appearance), decreased skin turgor with tenting (delayed recoil), absence of diaphoresis leading to impaired thermoregulation and elevated body temperature.
  • Renal: Oliguria ($< 30\,\text{mL/hr}$ of urine) with concentrated, dark urine.
  • Gastrointestinal: Constipation.
  • Body Weight: Acute weight loss. Body weight is the single most reliable indicator of fluid volume status ($2\,\text{lbs} = 1\,\text{L}$ of retained fluid).
• Diagnostic Findings and Complications:
  • Serum blood urea nitrogen (BUN) and hematocrit are falsely elevated due to hemoconcentration.
  • Complications: Hypoperfusion, cellular hypoxia, tissue ischemia, organ failure, and hypovolemic shock.
• Therapeutic Interventions:
  • Rehydration via oral intake (if tolerated) or intravenous therapy.
  • Administration of isotonic fluids ($0.9\%$ sodium chloride).
  • Continuous monitoring of daily weights, strict intake and output (I&O), and patient education.
  • In congestive heart failure (CHF) patients presenting with peripheral edema and intravascular dehydration, aggressive fluid administration must be strictly avoided to prevent overwhelming myocardial capacity.

Fluid Volume Excess (Overhydration and Hypervolemia)

• Pathophysiology and Etiology:
  • Excess fluid volume within the body leading to circulatory volume overload (hypervolemia).
  • Primary renal causes: Renal failure, renal insufficiency, or acute kidney injury impairing fluid filtration and excretion.
  • Iatrogenic causes: Poorly controlled intravenous fluid therapy (e.g., infusing replacement bags without an active healthcare provider prescription).
  • Excess sodium intake: High dietary sodium intake (e.g., salty foods) triggers systemic fluid retention ("wherever sodium goes, water flows").
  • Neuroendocrine and Pharmacologic: Corticosteroid therapy, adrenal gland disorders, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH), which causes pathological hypersecretion of ADH and severe systemic water retention.
• Clinical Manifestations:
  • Cardiovascular: Hypertension, bounding pulse, tachycardia, jugular venous distention (JVD).
  • Respiratory: Tachypnea, dyspnea, labored breathing, bilateral pulmonary adventitious sounds (crackles/rales).
  • Systemic and Integumentary: Dependent pitting edema, cool and pale skin.
  • Peritoneal: Ascites.
  • Renal: Polyuria (if renal function remains intact; absent in end-stage renal disease).
  • Body Weight: Acute weight gain ($2\,\text{lbs} = 1\,\text{L}$ of fluid retained).
• Diagnostic Findings and Complications:
  • Serum BUN and hematocrit levels are decreased due to hemodilution.
  • Complications: Decompensation into congestive heart failure, acute pulmonary edema, and multi-organ failure.
• Therapeutic Interventions:
  • Patient positioning: Elevation of the head of the bed (HOB) to ease respiratory effort.
  • Supplemental oxygen administration.
  • Pharmacotherapy: Diuretic administration (e.g., loop diuretics such as furosemide [Lasix]); requires continuous serum potassium monitoring.
  • Dietary modifications: Strict sodium-restricted diet and daily fluid restriction.
  • Renal replacement therapy (hemodialysis) if kidneys cannot excrete fluid.

Sodium ($\text{Na}^+$) Imbalances

• General Characteristics:
  • Most abundant extracellular cation.
  • Regulated primarily by aldosterone and renal excretion.
  • Directly governs fluid distribution ("wherever sodium goes, water flows").
  • Normal reference range: $135-145\,\text{mEq/L}$.
• Hyponatremia ($< 135\,\text{mEq/L}$):
  • Etiology: Inadequate intake (prolonged NPO), excessive sodium loss (severe diaphoresis, persistent vomiting, diarrhea, gastrointestinal nasogastric [NG] suctioning), or dilutional hyponatremia from excessive fluid intake/retention.
  • Manifestations: Signs of dehydration (if hypovolemic); generalized weakness, elevated body temperature, nausea, vomiting, diarrhea (NVD), tachycardia, altered mental status, and neurological deficits. Mnemonic: "SALT LOSS".
  • Complications: Cerebral edema, seizures, respiratory depression/failure, coma, and death.
  • Management: Address underlying cause; administer oral or IV sodium replacement (if depleted); initiate strict fluid restrictions (if dilutional); monitor I&O and daily weights; hemodialysis for refractory cases.
• Hypernatremia ($> 145\,\text{mEq/L}$):
  • Etiology: Excessive dietary sodium intake (highly processed foods), hypertonic fluid administration, or impaired renal sodium excretion.
  • Manifestations: Intense polydipsia (extreme thirst), restlessness, agitation, altered mental status, skeletal muscle twitching, seizures, and respiratory failure.
  • Complications: Coma, respiratory arrest from neuromuscular exhaustion.
  • Management: Treat underlying cause; correct water deficit; administer diuretics if renal function is preserved; perform hemodialysis if kidneys fail; place patient on a low-sodium diet.

Potassium ($\text{K}^+$) Imbalances

• General Characteristics:
  • Most abundant intracellular cation (conceptualized as "Circle K").
  • Essential for skeletal, smooth, and cardiac muscle contraction.
  • Excreted primarily by the renal system.
  • Dosed clinically in milliequivalents ($\text{mEq}$), never milligrams ($\text{mg}$).
  • Normal reference range: $3.5-5.3\,\text{mEq/L}$.
• Hypokalemia ($< 3.5\,\text{mEq/L}$):
  • Etiology: Inadequate dietary intake, potassium-wasting diuretics (e.g., loop diuretics), corticosteroid therapy, gastrointestinal losses (vomiting, diarrhea, NG tube suctioning), and acute hemorrhage.
  • Manifestations: Muscle cramping, skeletal muscle flaccidity, shallow respirations, weak/irregular pulse, cardiac dysrhythmias, dizziness, nausea, and lethargy.
  • Diagnostics: Serum potassium level and continuous electrocardiogram (ECG/EKG) monitoring.
  • Management and Administration Safety:
  • Oral potassium replacement: Large tablets ("horse pills") that are typically extended-release; must NEVER be crushed. May be broken/split along scored lines; a liquid formulation must be prescribed if dysphagia is present.
  • Intravenous potassium replacement: NEVER ADMINISTER VIA IV PUSH (lethal injection agent; causes instantaneous cardiac arrest). Administer as a controlled, slow infusion diluted in normal saline; causes vascular irritation and localized burning.
  • Immediately notify the provider of critical lab values to avert fatal dysrhythmias.
  • Dietary sources: Increase consumption of bananas, dark leafy greens, avocados, and potatoes.
• Hyperkalemia ($> 5.3\,\text{mEq/L}$):
  • Etiology: Rare in patients with normal renal function; primarily caused by renal failure, excessive oral potassium supplementation, overuse of over-the-counter potassium-based salt substitutes, or potassium-sparing diuretics.
  • Manifestations: Profound muscle weakness, flaccid paralysis, hyperactive bowel sounds with diarrhea (body attempt to eliminate potassium), bradycardia, weak pulse, systemic hypotension, and progressive cardiac dysrhythmias.
  • Complications: Fatal cardiac dysrhythmias, cardiac arrest, and respiratory arrest.
  • Diagnostics: Serum potassium level and immediate continuous ECG/EKG telemetry.
  • Management: Discontinue all exogenous potassium sources and supplements; administer potassium-wasting loop diuretics (if renal function is adequate); administer sodium polystyrene sulfonate (binds potassium in the gastrointestinal tract for fecal elimination); administer lactulose (binds potassium and stimulates bowel evacuation); initiate hemodialysis in renal failure.

Calcium ($\text{Ca}^{2+}$) Imbalances

• General Characteristics:
  • Stored predominantly ($99\%$) in bones and teeth.
  • Essential for skeletal and cardiac muscle contraction, nerve impulse transmission, and blood coagulation.
  • Inversely related to serum phosphorus/phosphate (as phosphate rises, calcium declines).
  • Absorption is strictly dependent upon active Vitamin D.
  • Normal reference range: $8.2-10.2\,\text{mg/dL}$.
• Hypocalcemia ($< 8.2\,\text{mg/dL}$):
  • Etiology: Inadequate dietary intake, Vitamin D deficiency (inadequate sunlight, malabsorption), chronic bowel disorders, acute pancreatitis, elevated phosphate levels, and surgical trauma to or excision of the parathyroid glands.
  • Related Conditions: Osteoporosis (high prevalence in postmenopausal women due to altered absorption dynamics).
  • Manifestations: Hypotension, dysrhythmias, altered mental status, abdominal cramping, diarrhea, and hyperactive deep tendon reflexes (DTRs).
  • Pathognomonic Neuromuscular Signs:
  • Trousseau's Sign: Occlusion of brachial artery blood flow via inflation of a blood pressure cuff for $1-4\,\text{minutes}$ triggers carpal spasm (positive palmar flexion, adduction of the thumb, and finger twitching).
  • Chvostek's Sign: Percussion of the facial nerve anterior to the earlobe and over the zygomatic arch elicits unilateral twitching of facial muscles.
  • Complications: Laryngospasm, severe airway obstruction, seizures, coma, respiratory failure, cardiac arrest, and death.
  • Management: Dietary calcium enrichment alongside Vitamin D; oral calcium carbonate supplements (e.g., Tums taken $1-2\,\text{hours}$ postprandially); IV calcium administration (calcium gluconate or calcium chloride) for acute, severe tetany or following thyroid/parathyroid surgery.
• Hypercalcemia ($> 10.2\,\text{mg/dL}$, symptomatic typically when $> 11.0\,\text{mg/dL}$):
  • Etiology: Excessive calcium or Vitamin D intake (overconsumption of calcium carbonate antacids/Tums), renal failure, malignancies (an oncological emergency involving bone destruction), prolonged use of thiazide diuretics, and hyperparathyroidism.
  • Manifestations: Early tachycardia and hypertension, progression toward myocardial failure, skeletal muscle weakness, hyporeflexia, and diminished gastrointestinal motility leading to severe constipation.
  • Complications: Nephrolithiasis (renal calculi / kidney stones) due to calcium precipitation in the renal parenchyma; acute respiratory failure.
  • Management: Aggressive intravenous hydration with isotonic saline to promote renal calcium excretion; continuous cardiac monitoring; discontinuation of thiazide diuretics; renal replacement therapy (hemodialysis).

Magnesium ($\text{Mg}^{2+}$) Imbalances

• General Characteristics:
  • Directly parallels calcium balance: an imbalance in serum magnesium typically induces a concurrent imbalance in calcium.
  • Normal reference range: $1.6-2.2\,\text{mEq/L}$.
• Hypomagnesemia ($< 1.6\,\text{mEq/L}$):
  • Etiology: Malnutrition, malabsorption syndromes, chronic diarrhea, vomiting, nasogastric suctioning, and chronic alcoholism.
  • Manifestations: Neuromuscular excitability and signs identical to hypocalcemia (hyperactive DTRs, tremors, muscle cramps, tetany, positive Trousseau's and Chvostek's signs, cardiac dysrhythmias).
  • Management: Oral or intravenous magnesium replacement; concurrent correction of secondary hypocalcemia.
• Hypermagnesemia ($> 2.2\,\text{mEq/L}$):
  • Etiology: Excessive magnesium administration (antacids, laxatives), impaired renal excretion, or end-stage renal disease.
  • Manifestations: Typically clinically silent until levels become significantly elevated; symptoms mirror hypercalcemia: bradycardia, arterial hypotension, peripheral vasodilation, depressed deep tendon reflexes, severe lethargy, and skeletal muscle flaccidity.
  • Complications: Respiratory failure from diaphragmatic paralysis, coma, and cardiac arrest.
  • Management: Intravenous fluid hydration to enhance renal clearance, administration of loop diuretics, alteration of medications, and hemodialysis.

Arterial Blood Gas (ABG) Foundations and Regulatory Systems

• Laboratory Reference Ranges:
  • $\text{pH}$: $7.35-7.45$
  • $\text{PaCO}_2$ (Respiratory Component): $32-45\,\text{mmHg}$ (carbon dioxide converts to carbonic acid; acts as the acidic determinant).
  • $\text{HCO}_3^-$ (Metabolic/Renal Component): $20-26\,\text{mEq/L}$ (bicarbonate acts as the alkaline/basic determinant).
• Systemic Compensation Mechanics:
  • Compensated: The secondary organ system alters its function to return systemic $\text{pH}$ toward normal limits.
  • Partially Compensated: The secondary organ system is actively adjusting, but the systemic $\text{pH}$ remains outside normal physiological ranges.
  • Uncompensated: The $\text{pH}$ is abnormal and only one regulatory component ($\text{PaCO}_2$ or $\text{HCO}_3^-$) is abnormal; the opposite component remains normal.
• Triad of Acid-Base Regulation:
  • Chemical Buffer Systems: Cellular buffers respond instantly to bind or release hydrogen ions.
  • Respiratory System (Lungs): Regulates $\text{PaCO}_2$ within minutes to hours. If serum is acidotic, hyperventilation blows off $\text{CO}_2$ to reduce acidity. If serum is alkalotic, hypoventilation retains $\text{CO}_2$ to increase acidity.
  • Renal System (Kidneys): Regulates $\text{HCO}_3^-$ over hours to days. In acidosis, kidneys reabsorb and synthesize bicarbonate while excreting hydrogen ions. In alkalosis, kidneys excrete bicarbonate into the urine.

Diagnostic Interpretation of Acid-Base Disorders

• Systematic Step-by-Step Interpretation:
  • Step 1: Analyze the $\text{pH}$.
  • $\text{pH} < 7.35 = \text{Acidosis}$.
  • $\text{pH} > 7.45 = \text{Alkalosis}$.
  • Step 2: Apply the ROME Mnemonic:
  • RO (Respiratory Opposite): In respiratory disorders, $\text{pH}$ and $\text{PaCO}_2$ arrows move in opposite directions.
    • $\text{pH} < 7.35$ and $\text{PaCO}_2 > 45\,\text{mmHg} = \text{Respiratory Acidosis}$.
    • $\text{pH} > 7.45$ and $\text{PaCO}_2 < 32\,\text{mmHg} = \text{Respiratory Alkalosis}$.
  • ME (Metabolic Equal): In metabolic disorders, $\text{pH}$ and $\text{HCO}_3^-$ arrows move in the same direction.
    • $\text{pH} < 7.35$ and $\text{HCO}_3^- < 20\,\text{mEq/L} = \text{Metabolic Acidosis}$.
    • $\text{pH} > 7.45$ and $\text{HCO}_3^- > 26\,\text{mEq/L} = \text{Metabolic Alkalosis}$.
• Respiratory Acidosis:
  • Laboratory Profile: $\text{pH} < 7.35$; $\text{PaCO}_2 > 45\,\text{mmHg}$.
  • Compensatory Response: Kidneys reabsorb and synthesize bicarbonate, driving $\text{HCO}_3^- > 26\,\text{mEq/L}$.
  • Etiology: Pulmonary hypoventilation and carbon dioxide retention caused by chronic obstructive pulmonary disease (COPD), central nervous system depression from opioid overdose, or acute respiratory failure.
  • Manifestations: Hypoventilation, dyspnea, somnolence, disorientation, altered mental status, and morning headache (from cerebral vasodilation secondary to hypercapnia).
• Metabolic Acidosis:
  • Laboratory Profile: $\text{pH} < 7.35$; $\text{HCO}_3^- < 20\,\text{mEq/L}$.
  • Compensatory Response: Lungs blow off carbon dioxide, resulting in $\text{PaCO}_2 < 32\,\text{mmHg}$ via Kussmaul's respirations (rapid, deep breathing patterns).
  • Etiology: Diabetic ketoacidosis (DKA) / severe hyperglycemia, lactic acidosis, end-stage renal failure, severe diarrhea, or excessive lower gastrointestinal suctioning (loss of alkaline secretions).
  • Manifestations: Kussmaul's respirations, arterial hypotension, headache, lethargy, confusion, nausea, and vomiting.
• Medical and Pharmacological Interventions for Acidosis:
  • Target the primary underlying etiology.
  • Diabetic ketoacidosis: Administer intravenous regular insulin to stop ketoacid production.
  • Renal failure: Initiate hemodialysis to clear metabolic waste and correct acid buildup.
  • Respiratory failure: Administer bronchodilators, provide mechanical ventilation, and reverse opioid depression.
  • Refractory systemic acidosis: Administer intravenous sodium bicarbonate ($\text{NaHCO}_3$) to neutralize systemic hydrogen ion concentrations.

Clinical Illustrative Cases and Real-World Examples

• Hypernatremia and Dietary Sodium Retention:
  • Consuming a high-sodium meal (e.g., an entire basket of tortilla chips at a Mexican restaurant) causes systemic water retention the following day, making rings difficult to remove from fingers due to peripheral fluid pooling.
• Excessive Calcium Ingestion and Renal Calculi:
  • A student managing an untreated gastric ulcer consumed excessive calcium carbonate antacids (Tums) daily like candy.
  • The chronic overconsumption caused hypercalcemia, which directly manifested as severe chronic constipation (decreased gastrointestinal motility) and recurrent nephrolithiasis (kidney stones).
• Medication Administration Safety Anecdotes:
  • An operational warning highlights charting errors where clinicians documented potassium orders in milligrams ($\text{mg}$) rather than milliequivalents ($\text{mEq}$).
  • A patient with renal failure receiving lactulose developed frequent bowel evacuations to lower systemic potassium, demonstrating how medication side effects (diarrhea) function as the primary therapeutic mechanism.
  • The inclusion of potassium chloride in lethal injection protocols emphasizes the fatal consequence of administering intravenous potassium by direct IV push.

Questions and Classroom Interactions

• Question on ADH Function:
  • Prompt: What is a diuretic medication, and what does antidiuretic hormone do?
  • Response: A diuretic medication (such as furosemide [Lasix]) promotes urinary excretion ("makes you pee"). Antidiuretic hormone (ADH) acts in the exact opposite manner, signaling the renal system to retain water.
• Question on Range of Motion Analogy:
  • Prompt: What is the distinction between active and passive range of motion, and how does it relate to cellular transport?
  • Response: Active range of motion requires independent effort and energy expenditure, mirroring active transport ($\text{Na}^+/\text{K}^+\text{-ATPase}$ pump requiring $\text{ATP}$). Passive range of motion requires an external force without personal energy use, mirroring passive cellular processes like diffusion, filtration, and osmosis.
• Question on Tongue Morphology in Dehydration:
  • Prompt: What was the specific clinical term used for the appearance of the tongue in dehydration?
  • Response: Furrows of the tongue, characterized by a cracked, dried-out surface indicating severe fluid loss.
• Question on Weight-to-Volume Conversion:
  • Prompt: What is the clinical formula correlating acute weight shifts with fluid volume?
  • Response: A change of $2\,\text{lbs}$ corresponds directly to $1\,\text{L}$ ($1000\,\text{mL}$) of retained or lost fluid.
• Question on Swallowability of Potassium:
  • Prompt: Is a potassium tablet larger than a prenatal vitamin?
  • Response: Yes, potassium tablets are large "horse pills" that are coated and cannot be crushed. They must be split along score lines or converted to a liquid formulation for patients with dysphagia.
• Question on Arterial Blood Gas Reference Values:
  • Prompt: In the respiratory chapter, was bicarbonate listed as $22-26\,\text{mEq/L}$, and what range should be memorized here?
  • Response: For this curriculum unit, memorize $20-26\,\text{mEq/L}$ for bicarbonate ($\text{HCO}_3^-$) and $32-45\,\text{mmHg}$ for $\text{PaCO}_2$. Examination questions utilize distinctly abnormal values to prevent ambiguity between slight reference range variations.